A major review details how AI enhances early detection and recurrence prediction in breast cancer imaging.
Key Details
- 1Systematic review covers research from 2006–2025 on AI in breast cancer imaging.
- 2AI-assisted mammography detects 29% more cancers compared to conventional reading without increasing false positives.
- 3AI reduces mammography reading time by ~40%, increasing radiologist efficiency.
- 4AI in 3D digital breast tomosynthesis finds 1.6 more cancers per 1,000 screens and reduces recall rate by 2.2%.
- 5AI in MRI identified imaging features up to one year pre-diagnosis and localized future cancer in 57% of cases.
- 6AI models also improve ultrasound interpretation consistency and biopsy analysis for recurrence risk.
Why It Matters
The review synthesizes evidence showing that AI not only boosts diagnostic accuracy and efficiency across imaging modalities, but also supports risk prediction and precision medicine. This highlights the growing value of AI as a clinical decision-support tool in breast imaging and underscores the challenges ahead for broad, equitable clinical adoption.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.